A Conversation With The Leader Of The National Cancer Institute
In May, 2015 Dr. Douglas Lowy, Acting Director of the National Cancer Institute, visited the Seidman Cancer Center at University Hospitals. Dr. Lowy received the second annual Harrington Prize for Innovation in Medicine for his work in developing the human papillomavirus (HPV) vaccine to prevent cervical cancer, as well as other types of cancers. During his visit, Dr. Lowy sat down with ideastream’s Kay Colby to talk about the HPV vaccine, as well as other issues related to cancer research including funding challenges and disparities affecting racial and ethnic groups.
Acting Director of the National Cancer Institute, Dr. Douglas Lowy, discusses his role in developing the first vaccine to protect against certain strains of the sexually transmitted infection known as the human papillomavirus (HPV) and its underutilization as a cancer prevention tool.
Dr. Lowy talks about the challenges of his new position leading the National Cancer Institute (NCI), as well as explains translational research and new areas of focus such as using precision medicine for cancer prevention and screening.
Dr. Lowy talks about the need to close the gap between survival rates for African American and whites for certain cancers, as well as the importance of using multi-faceted approaches to target cancer disparities.